v3 Template
N
NLS Pharmaceutics Ltd.
Pharmaceuticals / Healthcare
Zurich, Switzerland
Founded
--
Employees
--
Total Funding
$8.8M
Funding Rounds
7
Last Funding
2025-06-30
About NLS Pharmaceutics Ltd.
NLS Pharmaceutics is dedicated to redefining therapies for central nervous system (CNS) disorders. Founded in 2015, their mission is to safeguard life and longevity by empowering the brain through all stages of life. They focus on developing safe, effective, and better-tolerated drugs to improve mental and behavioral disorders, addressing conditions like narcolepsy and ADHD, which affect millions globally.
Products & Services
Central Nervous System (CNS) Therapies: Drugs and treatments aimed at improving mental and behavioral disorders such as narcolepsy and ADHD.
Specialties
Central Nervous System (CNS) Disorders
Narcolepsy Treatment
ADHD Treatment
Funding History
Debug: View Raw Funding Data
| # | Type | Amount Fields | Date Fields | Investors |
|---|---|---|---|---|
| 1 |
RT: Equity T: - FT: Equity |
A: 1000000 MR: - FA: $1 Million FAN: 1000000 |
D: 2025-06-30 FD: 2025-06-30 |
- |
| 2 |
RT: Equity Financing T: - FT: Equity Financing |
A: 2000000 MR: - FA: $2 million (with potential additional $1 million) FAN: 2000000 |
D: 2025-03-28 FD: 2025-03-28 |
- |
| 3 |
RT: Equity Financing T: - FT: Equity Financing |
A: 500000 MR: - FA: $500,000 FAN: 500000 |
D: 2025-01-08 FD: 2025-01-08 |
1 investors |
| 4 |
RT: Private Placement T: - FT: Private Placement |
A: 1000000 MR: - FA: up to $1.0 million FAN: 1000000 |
D: 2024-12-04 FD: 2024-12-04 |
- |
| 5 |
RT: Registered Direct Offering T: - FT: Registered Direct Offering |
A: 786660 MR: - FA: $786,660 FAN: 786660 |
D: 2024-06-28 FD: 2024-06-28 |
1 investors |
| 6 |
RT: Registered Direct Offering T: - FT: Registered Direct Offering |
A: 1750000 MR: - FA: 1.75 million FAN: 1750000 |
D: 2024-03-22 FD: 2024-03-22 |
1 investors |
| 7 |
RT: Registered Direct Offering T: - FT: Registered Direct Offering |
A: 1750000 MR: - FA: $1.75 million FAN: 1750000 |
D: 2024-03-20 FD: 2024-03-20 |
- |
Equity
Latest
2025-06-30
$1.0M
Equity Financing
2025-03-28
$2.0M
Equity Financing
2025-01-08
$500K
Growth Metrics
+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active
Mock Up
Team & Leadership
No team data available
Team information is not yet available for this company
Recent News
NLS Pharmaceutics Ltd. Announces New Product Launch
2 days agoCompany unveils innovative solution to transform the industry, expanding market reach and capabilities...
Read more →Leadership Team Expands with Industry Veteran
1 week agoNew executive brings 20+ years of experience to accelerate growth and strategic initiatives...
Read more →Company Recognized as Industry Leader
2 weeks agoReceives prestigious award for innovation and customer satisfaction in competitive market...
Read more →Mock Up
Key Competitors
C1
Competitor Alpha
Series B · $50M raised
C2
Competitor Beta
Series C · $120M raised
C3
Competitor Gamma
Series A · $25M raised
C4
Competitor Delta
Seed · $10M raised
Mock Up
Company Details
- Website
- nlspharma.com
- Industries
- Pharmaceuticals / Healthcare
- Locations
-
Zurich, Switzerland
Zürich, Switzerland
Similar Companies
Discover AI-powered company recommendations based on industry, funding, and team profiles.
Upgrade to ProTechnology Stack
Discover the backend, frontend, and infrastructure technologies powering this company's products.
Upgrade to Pro